Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

NOVOLIN GE TORONTO PENFILL

NOVO NORDISK CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is NOVOLIN GE TORONTO PENFILL discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that NOVOLIN GE TORONTO PENFILL 100UNIT has been permanently discontinued (last updated June 5, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is NOVOLIN GE TORONTO PENFILL not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products
Affected strength100UNIT
Last updated2026-06-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

NOVOLIN GE TORONTO

NOVO NORDISK CANADA INC

100UNIT · DIN 02024233

Same strengthSame dosage formSame routeNo current shortage

HUMULIN R CARTRIDGE

ELI LILLY CANADA INC

100UNIT · DIN 01959220

Same strengthSame dosage formSame routeNo current shortage

Other Products

NOVOLINSET GE TORONTO INJ LIQ 100U/ML

NOVO NORDISK A/S

100UNIT · DIN 02025256

Same strengthDifferent dosage formSame routeNo current shortage

ENTUZITY KWIKPEN

ELI LILLY CANADA INC

500UNIT · DIN 02466864

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02024284

Strength

100UNIT

Dosage Form

SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR

Active Ingredient

INSULIN INJECTION HUMAN BIOSYNTHETIC

See all INSULIN INJECTION HUMAN BIOSYNTHETIC products →

Shortage History